Qualigen Therapeutics Announces First Patient Dosed In The Phase 1a Clinical Trial Of QN-302 For Treatment Of Advanced Or Metastatic Solid Tumors
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
A impatient, emotional investor with 200 IQ will lose against a patient, non-emotional investor with 90 IQ.
39Followers
82Following
197Visitors
Follow